Torrey, E.F., and M. Zdanowicz. “Outpatient Commitment: What, Why, and for Whom?” Psychiatric Services 53 (2001): 337–41.

Torrey, E.F., J. Stieber, J. Ezekiel, et al. Criminalizing the Seriously Mentally Ill: The Abuse of Jails as Mental Hospitals. Washington, D.C.: Health Research Group and National Alliance for the Mentally Ill, 1992.

Torrey, E.F., M.T. Zdanowicz, A.D. Kennard, et al. “The Treatment of Persons with Mental Illness in Prisons and Jails: A State Survey.” Treatment Advocacy Center (2014). http://www.treatmentadvocacycenter.org/storage/documents/treatment-behind-bars/treatment-behind-bars.pdf

Velligan, D.I., M. Sajatovic, A. Hatch, A. et al. “Why do Psychiatric Patients Stop Antipsychotic Medication? A Systematic Review of Reasons for Nonadherence to Medication in Patients with Serious Mental Illness.” Patient Preference and Adherence 11 (2017): 449–68.

Цитируемые источники

Anonymous, “Admissions to Hospitals for the Insane,” American Journal of Insanity 25 (1868): 74.

F. Dickerson, J. Schroeder, E. Katsafanas, et al., “Cigarette Smoking by Patients with Serious Mental Illness, 1999–2016: An Increasing Disparity,” Psychiatric Services 69 (2018): 147–53.

C. Cather, G.N. Pachas, K.M. Cieslak, et al., “Achieving Smoking Cessation in Individuals with Schizophrenia,” CNS Drugs 31 (2017): 471–81.

F. Dickerson, M.B. Adamos, E. Katsafanas et al., “The Association Among Smoking, HSV-1 Exposure, and Cognitive Functioning in Schizophrenia, Bipolar Disorder, and Non- Psychiatric Controls,” Schizophrenia Research 176 (2016): 566–71.

J. I. Benson and J.J. David, “Coffee Eating in Chronic Schizophrenic Patients,” American Journal of Psychiatry 143 (1986): 940–41.

P. B. Lucas, D. Pickar, J. Kelsoe, et al., “Effects of the Acute Administration of Caffeine in Patients with Schizophrenia,” Biological Psychiatry 28 (1990): 35–40.

S. R. Hirsch, “Precipitation of Antipsychotic Drugs in Interaction with Coffee or Tea,” letter, Lancet 2 (1979): 1130–31.

M. O. Zaslove, R.L. Russell, and E. Ross, “Effect of Caffeine Intake on Psychotic In-Patients,” British Journal of Psychiatry 159 (1991): 565–67.

F. Kulhanek, O.K. Linde, and G. Meisenberg, “Precipitation of Antipsychotic Drugs in Interaction with Coffee or Tea,” letter, Lancet 2 (1979): 1130.

J. A. Cabarillo, A.G. Herraiz, S.I. Ramos, et al., “Effects of Caffeine Withdrawal from the Diet on the Metabolism of Clozapine in Schizophrenic Patients,” Journal of Clinical Psychopharmacology 18 (1998): 311–16.

D. A. Regier, M.E. Farmer, D.S. Rae, et al., “Comorbidity of Mental Disorders with Alcohol and Other Drug Abuse,” Journal of American Medical Association 264 (1990): 2511–18.

Substance Abuse and Mental Health Services Administration, Results from the 2002 National Survey on Drug Use and Health: Detailed Tables (U.S. Department of Health and Human Services, 2003).

C. A. Pristach and C.M. Smith, “Self-Reported Effects of Alcohol Use on Symptoms of Schizophrenia,” Psychiatric Services 47 (1996): 421–23.

R. E. Drake and M.A. Wallach, “Substance Abuse among the Chronically Ill,” Hospital and Community Psychiatry 40 (1989): 1041–46.

M. S. Swartz, J.W. Swanson, and M.J. Hannon, “Detection of Illicit Substance Use among Persons with Schizophrenia by Radioimmunoassay of Hair,” Psychiatric Services 54 (2003): 891–95.

S. J. Kingsbury and C. Salzman, “Disulfiram in the Treatment of Alcoholic Patients with Schizophrenia,” Hospital and Community Psychiatry 41 (1990): 133–34.

R. Warner, D. Taylor, J. Wright, et al., “Substance Use among the Mentally Ill: Prevalence, Reasons for Use, and Effects on Illness,” American Journal of Orthopsychiatry 64 (1994): 30–39.

V. Peralta and M.J. Cuesta, “Influence of Cannabis Abuse on Schizophrenic Psychopathology,” Acta Psychiatrica Scandinavica 85 (1992): 127–30.

J. Coverdale, J. Aruffo, and H. Grunebaum, “Developing Family Planning Services for Female Chronic Mentally Ill Outpatients,” Hospital and Community Psychiatry 43 (1992): 475–77.

J. A. Kelly, D.A. Murphy, G.R. Bahr, et al., “AIDS/HIV Risk Behavior among the Chronically Mentally Ill,” American Journal of Psychiatry 149 (1992): 886–89.

K. McKinnon, F. Courrios, H.F.L. Meyer-Bahlburg, et al., “Reliability of Sexual Risk Behavior Interviews with Psychiatry Patients,” American Journal of Psychiatry 150 (1993): 972–74.

D. Civic, G. Walsh, and D. Mc-Bride, “Staff Perspectives on Sexual Behavior of Patients in a State Psychiatric Hospital,” Hospital and Community Psychiatry 44 (1993): 887–90.

K. Bhui, A. Puffet, and G. Strathdee, “Sexual and Relationship Problems amongst Patients with Severe Chronic Psychoses,” Social Psychiatry and Psychiatric Epidemiology 32 (1997): 459–67.

M. B. Rosenbaum, “Neuroleptics and Sexual Functioning,” Integrative Psychiatry 4 (1986): 105–6.

G. Sullivan and D. Lukoff, “Sexual Side Effects of Antipsychotic Medication: Evaluation and Interventions,” Hospital and Community Psychiatry 41 (1990): 1238–41.

S. Smith, P. Mostyn, S. Vearnals, et al., “The Prevalence of Sexual Dysfunction in Schizophrenic Patients Taking Conventional Antipsychotic Medication,” Schizophrenia Research 41 (2000): 218.

D. D. Gold and J.D. Justino, “‘Bicycle Kickstand’ Phenomenon: Prolonged Erections Associated with Antipsychotic Drugs,” Southern Medical Journal 81 (1988): 792–94.

M. V. Seeman, M. Lang, and N. Rector, “Chronic Schizophrenia: A Risk Factor for HIV?” Canadian Journal of Psychiatry 35 (1990): 765–68.

J. H. Coverdale and J.A. Aruffo, “Family Planning Needs of Female Chronic Psychiatric Outpatients,” American Journal of Psychiatry 146 (1989): 1489–91.

L. M. Howard, G. Thornicroft, M. Salmon, et al., “Predictors of Parenting Outcome in Women with Psychotic Disorders Discharged from Mother and Baby Units,” Acta Psychiatrica Scandinavica 110 (2004): 347–55.

M. Mullick, L.J. Miller, and T. Jacobsen, “Insight into Mental Illness and Child Maltreatment Risk among Mothers with Major Psychiatric Disorders,” Psychiatric Services 52 (2001): 488–92.

L. B. McCullough, J. Coverdale, T. Bayer, et al., “Ethically Justified Guidelines for Family Planning Interventions to Prevent Pregnancy in Female Patients with Chronic Mental Illness,” American Journal of Obstetrics and Gynecology 167 (1992): 19–25.

B. E. Bennedsen, P.B. Mortensen, A.V. Olesen, et al., “Preterm Birth and Intra-Uterine Growth Retardation among Children of Women with Schizophrenia,” British Journal of Psychiatry 175 (1999): 239–45.

A. Jablensky, S. Zubrick, V. Morgan, et al., “The Offspring of Women with Schizophrenia and Affective Psychoses: A Population Study,” Schizophrenia Research 41 (2000): 8.

A. Buist, T.R. Norman, and L. Dennerstein, “Breastfeeding and the Use of Psychotropic Medication: A Review,” Journal of Affective Disorders 19 (1990): 197–206.

D. Gamino, “1 in 24 New Austin State Hospital Patients Has HIV,” Austin American- Statesman, August 22, 1991.

F. Cournos, M. Empfield, E. Horwath, et al., “HIV Seroprevalence among Patients Admitted to Two Psychiatric Hospitals,” American Journal of Psychiatry 148 (1991): 1225–30.

M. Sacks,